Remove 2027 Remove Electronics Remove IT Remove Patients
article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

Starting next year, if a patient switches insurance plans while getting treatment, the new plan must honor the old plan’s prior authorization for at least 90 days. Starting next year, if a patient switches insurance plans while getting treatment, the new plan must honor the old plan’s prior authorization for at least 90 days.

article thumbnail

When Worlds Collide: The Theory of Real-World Evidence Meets Reality

FDA Law

FDA recognizes the potential of RWE to support regulatory submissions of medical devices and to inform benefit-risk analysis of such products, while assuring patients have timely access to devices. RWE is “the clinical evidence regarding the usage, and potential benefits or risks, of a medical product derived from analysis of RWD.”

Medical 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RWE There Yet? FDA’s New Pilot Program Seeks to Help Usher in a New Era for Real World Evidence

FDA Law

These data are routinely collected from a variety of sources, such as electronic health records, providing information on health and healthcare in actual patients, rather than in the controlled environment of a clinical trial. There will be two submission deadlines per year on March 31 and September 30, through March 31, 2027.

article thumbnail

5 Takeaways From Health Insurers’ New Pledge To Improve Prior Authorization

Physician's Weekly

Insurers also pledged to use clear language when communicating with patients and promised that medical professionals would review coverage denials. But health policy analysts say prior authorization — a system that forces some people to delay care or abandon treatment — may continue to pose serious health consequences for affected patients.